Back
Perspective Therapeutics Stock Price Chart
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
CATX
Perspective Therapeutics
Last Price:
$1.97
Seasonality Move:
8.36%
7 Day Trial
ALL ACCESS PASS
$
7
How to target income on Weekend Liquidity.
You can Watch it Here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.88 | Buy |
| 20-day SMA: | 2.17 | Sell |
| 50-day SMA: | 2.62 | Sell |
| 200-day SMA: | 8.04 | Sell |
| 8-day EMA: | 1.92 | Buy |
| 20-day EMA: | 2.13 | Sell |
| 50-day EMA: | 2.7 | Sell |
| 200-day EMA: | 6.23 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 38.53 | Sell |
| Chaikin Money Flow: | 612718 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.94 - 2.56) | Sell |
| Bollinger Bands (100): | (2.12 - 4.4) | Sell |
Perspective Therapeutics Technical Analysis
| Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 1.95 while CATX 8-day simple moving average is 1.88, which is a Buy signal.
-
The stock price of CATX is 1.95 while Perspective Therapeutics 20-day SMA is 2.17, which makes it a Sell.
-
Perspective Therapeutics 50-day simple moving average is 2.62 while CATX share price is 1.95, making it a Sell technically.
-
CATX stock price is 1.95 and Perspective Therapeutics 200-day simple moving average is 8.04, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a SellThe current Perspective Therapeutics [CATX] share price is $1.95. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
144.4M
Price in USD:
1.95
Share Volume:
1M
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
1.60
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?The Perspective Therapeutics stock price is 1.95 USD today.
-
Will CATX stock go up or go down?Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Perspective Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 1.95 while CATX 8-day exponential moving average is 1.92, which is a Buy signal.
-
The stock price of CATX is 1.95 while Perspective Therapeutics 20-day EMA is 2.13, which makes it a Sell.
-
Perspective Therapeutics 50-day exponential moving average is 2.70 while CATX share price is 1.95, making it a Sell technically.
-
CATX stock price is 1.95 and Perspective Therapeutics 200-day simple moving average is 6.23, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.27 per share, and a decrease next year of $0.22 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
-
CATX Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Perspective Therapeutics is a Sell
-
Perspective Therapeutics Relative Strength Index (RSI) is 38.53, which suggest Perspective Therapeutics is oversold
-
The Bollinger Bands (25) for Perspective Therapeutics is (1.94 - 2.56), which suggest Perspective Therapeutics is a Sell
-
The Bollinger Bands (100) for Perspective Therapeutics is (2.12 - 4.4), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.